A Glimpse Into The Expert Outlook On Sotera Health Through 4 …

Mar 11, 2024 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $19.0, a high estimate of $20.00, and a low estimate of …

CouponFollow Extension

$19
OFF

A Glimpse Into The Expert Outlook On Sotera Health Through 4 …

1 week from now

Mar 11, 2024 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $19.0, a high estimate of $20.00, and a low estimate of …

businessinsider.com

$0.26
OFF

Unveiling Sotera Health Company (SHC) Q4 Outlook: Wall

1 week from now

Feb 22, 2024 · Wall Street analysts forecast that Sotera Health Company (SHC) will report quarterly earnings of $0.26 per share in its upcoming release, pointing to a year-over-year …

tradingview.com

0%
OFF

Sotera Health Reports Fourth-Quarter And Full-Year 2023 Results ...

1 week from now

Feb 27, 2024 · 2023 Adjusted EPS(1) decreased $0.15 to $0.81 per diluted share. Full-year 2024 outlook of 4.0% - 6.0% growth for Net Revenues and Adjusted EBITDA. CLEVELAND, Feb. …

yahoo.com

3%
OFF

Sotera Health Reports Third-Quarter And Year-to-Date 2024 Results

1 week from now

Nov 5, 2024 · For the third-quarter 2024, Sterigenics net revenues were $176 million, an increase of 4.3% compared to the third quarter a year ago. Third-quarter 2024 segment income was …

soterahealth.com

4%
OFF

Sotera Health Reports Fourth-Quarter And Full-Year 2022 …

1 week from now

Exhibit 99.1 1 Sotera Health Reports Fourth-Quarter and Full-Year 2022 Results; Provides 2023 Outlook • Q4 2022 net revenues increased 4% to $252 million, compared to Q4 2021 • Q4 …

soterahealth.com

5%
OFF

Sotera Health Reports Fourth-Quarter And Full-Year 2023 Results ...

1 week from now

Feb 27, 2024 · 2023 net revenues increased 4.5% to $1.05 billion, compared to 2022; 2023 net income of $51 million or $0.18 per diluted share; 2023 Adjusted EBITDA (1) increased 4.3% to …

marketscreener.com

5%
OFF

Sotera Health : Reports Third Quarter And Year To Date 2024 …

1 week from now

November 05, 2024 at 07:13 am EST. Sotera Health Reports Third-Quarter and Year-to-Date 2024 Results. •Q3 2024 net revenues of $285 million increased 8.5%, compared to Q3 2023. …

marketscreener.com

5%
OFF

Sotera Health Reports Third-Quarter And Year-to-Date 2024 Results

1 week from now

Nov 5, 2024 · Sotera Health Reports Third-Quarter and Year-to-Date 2024 Results. Provided by GlobeNewswire. Nov 5, 2024 4:00am. Q3 2024 net revenues of $285 million increased 8.5%, …

morningstar.com

$35
OFF

A Glimpse Into The Expert Outlook On APA Through 20 Analysts

1 week from now

Nov 8, 2024 · 0. In the assessment of 12-month price targets, analysts unveil insights for APA, presenting an average target of $35.6, a high estimate of $52.00, and a low estimate of …

nasdaq.com

$11
OFF

A Glimpse Into The Expert Outlook On Health Catalyst Through 4 …

1 week from now

Jul 9, 2024 · Analysts have set 12-month price targets for Health Catalyst, revealing an average target of $11.5, a high estimate of $14.00, and a low estimate of $8.00. A negative shift in …

businessinsider.com

FAQs about A Glimpse Into The Expert Outlook On Sotera Health Through 4 … Coupon?

How much did Sotera Health company (SHC) make in a quarter?

Compared to the present estimate, the company reported $89.06 million in the same quarter last year. Get a deeper insight into the potential performance of Sotera Health Company (SHC) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. ...

What is Sotera Health's revenue growth rate?

Revenue Growth: Sotera Health's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately 23.31%. This indicates a substantial increase in the company's top-line earnings. ...

Is Sotera Health a good company?

With an impressive ROA of 1.26%, the company demonstrates effective utilization of assets and strong financial performance. Debt Management: Sotera Health's debt-to-equity ratio surpasses industry norms, standing at 5.24. This suggests the company carries a substantial amount of debt, posing potential financial challenges. ...

What happened to BioScience Laboratories?

On May 1, 2022, BioScience Laboratories, based in Montana, was acquired by Sotera Health, a leading global provider of mission-critical sterilization and lab-testing and advisory services. Effective March 10, 2021, the company’s name was changed to Nelson Laboratories Bozeman. Download the Form W-9. ...

What challenges does Sotera Health face?

Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges. Revenue Growth: Sotera Health's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately 23.31%. ...

What do analyst ratings mean for Sotera Health?

These ratings convey the analysts' expectations for the relative performance of Sotera Health compared to the broader market. Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Sotera Health's stock. ...